Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cholangiocarcinoma × Association × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Myelodysplastic Syndromes 2 Leukemia, Myeloid, Acute 2 Sarcoma, Kaposi 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Leukemia, Prolymphocytic 1 Leukemia, Plasma Cell 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Hematologic Diseases 1 Cholangiocarcinoma 1 Burkitt Lymphoma 1

Interventions

Gemcitabine 69 Cisplatin 41 Oxaliplatin 31 lenvatinib 22 durvalumab 21 Capecitabine 21 Fluorouracil 18 Leucovorin 13 pembrolizumab 10 apatinib 10 Radiotherapy 10 Radiofrequency Ablation 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Taxes 7 Magnetic Resonance Spectroscopy 7 Liver Transplantation 7 Floxuridine 7 Drug Therapy 7 Cholangiopancreatography, Endoscopic Retrograde 7 tremelimumab 6 pemigatinib 6 Surgical Procedures, Operative 6 Photochemotherapy 6 Panitumumab 6 Irinotecan 6 Folfox protocol 6 130-nm albumin-bound paclitaxel 6 sintilimab 5 camrelizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01912053 2018-05-11

MispheC

Center Eugene Marquis

Phase 2 Completed

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡